About Ben Swett
Ben joined Irving Levin in the summer of 2014 as an Analyst, responsible for the research and reporting on seniors housing M&A and finance news for the Senior Care Investor, in addition to providing research and analysis for Irving Levin’s healthcare sector reports.
Ben graduated from Hamilton College with a B.A. in History (concentrating on the American Civil War) and minors in French and Economics. When not at the office, chances are you will find Ben on the tennis court.
by Ben Swett | Nov 30, 2021 2:15 pm | Financings |
Greystone arranged financing for a 193-unit seniors housing complex in Atlanta owned by Harbert Seniors Housing Fund I LP. Matt Miller of Greystone’s Senior Housing Capital Markets Team handled the transaction, which did not disclose loan amounts. However, a large... Read More »
by Ben Swett | Nov 29, 2021 10:24 am | Financings |
The team at JLL Capital Markets refinanced a couple of seniors housing properties in the Southeast, working with a debt fund in both transactions. The first, and largest, deal saw a five-year $57.5 million loan arranged for Windsor at Celebration, a... Read More »
by Ben Swett | Nov 29, 2021 10:20 am | Financings |
Ziegler closed a $16.645 million bond series for Oak Hammock at the University of Florida, Inc. (Oak Hammock), a not-for-profit corporation formed in 1998 to own and operate a large CCRC in Gainesville, Florida. The 135-acre campus consists of 269 independent living... Read More »
by Ben Swett | Nov 24, 2021 3:02 pm | Acquisitions |
Advantage Living Centers recently divested six of its senior care facilities in southeastern Michigan, with Walker & Dunlop’s Josh Jandris and Mark Myers handling the transaction. An undisclosed, New Jersey-based regional owner/operator bought the properties,... Read More »
by Ben Swett | Nov 24, 2021 9:38 am | 60 Seconds |
It has been another difficult year for the senior care industry, but there are certainly things to be thankful for and reasons to be optimistic for 2022. First, that the vaccines, booster shots and therapeutics are so successful at treating COVID, and that 98.5% of... Read More »
